GPT Healthcare Limited (GPTHEALTH) fundamentals
GPT Healthcare Limited is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as GPTHEALTH (ISIN INE486R01017). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What GPT Healthcare Limited does
GPT Healthcare Limited is an India-based company. The Company’s principal activities include the operation of multidisciplinary private hospitals and pharmacies. It has four multispecialty hospitals, two in Kolkata, Salt Lake, one in Agartala and one hospital in Howrah, West Bengal, and has one nursing institute in Agartala, under the brand name ILS Hospitals. ILS Hospitals, Agartala, has approximately 205 bedded multispecialty hospital with a 50 Seat B.Sc. Nursing College. ILS Hospitals, Agartala has operating theaters, a catheterization laboratory and other diagnostic and therapeutic equipment. The ILS Hospitals Dumdum has approximately 155 bedded multispecialty hospital with operation theaters, a catheterization laboratory and other diagnostic and therapeutic equipment. ILS Hospitals Howrah is a multi-specialty hospital which is equipped with over 116 beds. ILS Hospitals Salt Lake is a multispecialty hospital with approximately 85 beds and three operation theaters.
Valuation and market data
| Last close | ₹161.06 |
|---|---|
| Market capitalisation | ₹1,320 crore |
| Enterprise value | ₹1,432 crore |
| P/E (TTM) | 31.27 |
| Price to book | 4.90 |
| Price to sales (TTM) | 1.57 |
| Book value per share | ₹32.86 |
| Dividend yield | 155.22% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Thu Feb 29 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹479 crore | ₹55 crore | ₹42 crore | 5.15 |
| Mar 2025 | ₹416 crore | ₹69 crore | ₹50 crore | 6.08 |
| Mar 2024 | ₹405 crore | ₹68 crore | ₹48 crore | 5.96 |
| Mar 2023 | ₹367 crore | ₹56 crore | ₹39 crore | 4.88 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 65.6% |
|---|---|
| Foreign institutions (FII) | 3.0% |
| Mutual funds | 4.7% |
| Other domestic institutions | 2.3% |
| Retail and others | 24.5% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.